Evidence map›Paper›PMID 42527517›Full record

Reviewnpj health systems2026

Introduction of early health technology assessment for innovators, clinicians, and funders.

Teerawat Wiwatpanit, Yot Teerawattananon, Yi Wang

Abstract readReview
In one paragraph

Review in npj health systems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Teerawat WiwatpanitHealth Intervention and Technology Assessment Program Foundation , Nonthaburi, Thailand.
Yot TeerawattananonHealth Intervention and Technology Assessment Program Foundation , Nonthaburi, Thailand.
Yi WangSaw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore. ephwyi@nus.edu.sg.

Funding

Thailand Science Research and Innovation (TSRI) FFB670043/0401
6 · The paper itself

Abstract

Health technology faces rising costs, system complexities, and gaps between development and coverage policies, limiting translation into practice. Traditional health technology assessment (HTA) evaluates technologies at late stages, providing little support if a technology fails to secure reimbursement. Early HTA addresses this by assessing technologies during research and development stages, helping innovators prioritise disease areas, define target product profiles, and establish value propositions. Early HTA could reduce development risks and uncertainties and inform development choices that could improve cost-effectiveness and enhance long-term viability, adaptability, and adoptability in the healthcare system.

Identifiers

PMID42527517
PMCPMC13354158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.